HAE-话题@MedSci

#HAE#

411篇内容 | 2300人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2008428, encodeId=eae5200842831, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：血浆中甘露糖结合凝集素水平与静脉血栓栓塞风险, objectType=article, longId=169025, objectId=888f16902522, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=888f16902522, replyNumber=0, likeNumber=67, createdTime=2020-05-19, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=888f16902522, moduleTitle=J Thromb Haemost：血浆中甘露糖结合凝集素水平与静脉血栓栓塞风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=888f16902522)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008423, encodeId=7c9520084230d, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haemat：Guadecitabine用于中高危骨髓增生异常综合征患者的疗效和安全性, objectType=article, longId=165382, objectId=9da8165382e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da8165382e2, replyNumber=0, likeNumber=69, createdTime=2019-12-13, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da8165382e2, moduleTitle=Lancet Haemat：Guadecitabine用于中高危骨髓增生异常综合征患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9da8165382e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008416, encodeId=d62e200841659, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：静脉血栓栓塞后的身体活动与复发风险以及死亡率的关系, objectType=article, longId=164408, objectId=f6dc16440885, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6dc16440885, replyNumber=0, likeNumber=79, createdTime=2019-07-13, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6dc16440885, moduleTitle=J Thromb Haemost：静脉血栓栓塞后的身体活动与复发风险以及死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6dc16440885)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008441, encodeId=d47f2008441f9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：阿哌沙班和达肝素在活动性恶性肿瘤相关的静脉血栓栓塞中的疗效, objectType=article, longId=181698, objectId=611d181698e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=611d181698e9, replyNumber=0, likeNumber=54, createdTime=2020-09-20, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=611d181698e9, moduleTitle=J Thromb Haemost：阿哌沙班和达肝素在活动性恶性肿瘤相关的静脉血栓栓塞中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=611d181698e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008418, encodeId=5b58200841897, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haemat： Polatuzumab vedotin或Pinatuzumab vedotin联合利妥昔单抗用于复发性/难治性非霍奇金淋巴瘤的疗效, objectType=article, longId=164439, objectId=effa16443993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=effa16443993, replyNumber=0, likeNumber=67, createdTime=2020-03-09, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=effa16443993, moduleTitle=Lancet haemat： Polatuzumab vedotin或Pinatuzumab vedotin联合利妥昔单抗用于复发性/难治性非霍奇金淋巴瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=effa16443993)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008454, encodeId=a9f2200845493, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：抗胸腺蛋白抗体联合标准GVHD预防疗法可明显改善非亲缘供体移植血液恶性肿瘤患者的预后, objectType=article, longId=187105, objectId=5db718e105b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5db718e105b1, replyNumber=0, likeNumber=65, createdTime=2020-04-08, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5db718e105b1, moduleTitle=Lancet Haematol：抗胸腺蛋白抗体联合标准GVHD预防疗法可明显改善非亲缘供体移植血液恶性肿瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5db718e105b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008445, encodeId=f2c4200844527, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：新诊断MM诱导治疗反应深度不佳者强化治疗可进一步改善结果, objectType=article, longId=182770, objectId=81ec182e7056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81ec182e7056, replyNumber=0, likeNumber=105, createdTime=2020-02-01, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81ec182e7056, moduleTitle=Lancet Haematol：新诊断MM诱导治疗反应深度不佳者强化治疗可进一步改善结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81ec182e7056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008430, encodeId=fec82008430df, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematology：来那度胺联合Obinutuzumab单抗治疗复发或难治性滤泡性淋巴瘤, objectType=article, longId=175098, objectId=5aae1e5098dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5aae1e5098dd, replyNumber=0, likeNumber=75, createdTime=2019-09-06, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5aae1e5098dd, moduleTitle=Lancet Haematology：来那度胺联合Obinutuzumab单抗治疗复发或难治性滤泡性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5aae1e5098dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008408, encodeId=ef93200840829, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：直接口服抗凝药会增加脑肿瘤患者颅内出血风险吗？, objectType=article, longId=160808, objectId=9539160808ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9539160808ae, replyNumber=0, likeNumber=93, createdTime=2019-04-02, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9539160808ae, moduleTitle=J Thromb Haemost：直接口服抗凝药会增加脑肿瘤患者颅内出血风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9539160808ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008413, encodeId=ed432008413eb, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：新确诊急性髓性白血病老年患者：地西他滨5天vs 10天方案, objectType=article, longId=161613, objectId=37dd161613fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37dd161613fb, replyNumber=0, likeNumber=59, createdTime=2019-10-31, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37dd161613fb, moduleTitle=Lancet Haematol：新确诊急性髓性白血病老年患者：地西他滨5天vs 10天方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37dd161613fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008426, encodeId=99b8200842667, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：全血细胞计数、d-二聚体和可溶性P-选择素与癌症患者动脉血栓栓塞风险的关联, objectType=article, longId=166315, objectId=b4f516631583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4f516631583, replyNumber=0, likeNumber=86, createdTime=2020-04-11, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4f516631583, moduleTitle=J Thromb Haemost：全血细胞计数、d-二聚体和可溶性P-选择素与癌症患者动脉血栓栓塞风险的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4f516631583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008422, encodeId=7fee2008422f3, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haemat：A型血友病患者采用emicizumab预防出血的效果和安全性, objectType=article, longId=165179, objectId=f5ca1651e910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5ca1651e910, replyNumber=0, likeNumber=77, createdTime=2020-01-07, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5ca1651e910, moduleTitle=Lancet haemat：A型血友病患者采用emicizumab预防出血的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5ca1651e910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008427, encodeId=5c55200842ed7, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haemat：沙班类抗凝药用于病态肥胖患者的效果和安全性是否可媲美华法林？, objectType=article, longId=166866, objectId=615816686665, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=615816686665, replyNumber=0, likeNumber=63, createdTime=2020-02-16, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=615816686665, moduleTitle=Lancet Haemat：沙班类抗凝药用于病态肥胖患者的效果和安全性是否可媲美华法林？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=615816686665)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008415, encodeId=138d200841558, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：慢性免疫性血小板减少症患者心血管和出血结局, objectType=article, longId=163695, objectId=e77c163695e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e77c163695e7, replyNumber=0, likeNumber=69, createdTime=2019-06-20, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e77c163695e7, moduleTitle=J Thromb Haemost：慢性免疫性血小板减少症患者心血管和出血结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e77c163695e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008420, encodeId=a0182008420f2, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：Emicizumab用于A型血友病出血预防, objectType=article, longId=164518, objectId=97741645181b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97741645181b, replyNumber=0, likeNumber=63, createdTime=2019-07-18, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97741645181b, moduleTitle=Lancet Haematol：Emicizumab用于A型血友病出血预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97741645181b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008425, encodeId=fd00200842503, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：血液系统癌症患者血栓栓塞和出血的风险, objectType=article, longId=165562, objectId=93a71655627e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93a71655627e, replyNumber=0, likeNumber=91, createdTime=2020-02-06, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93a71655627e, moduleTitle=J Thromb Haemost：血液系统癌症患者血栓栓塞和出血的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93a71655627e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008434, encodeId=d0b820084346c, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematology：Nivolumab联合一线化疗治疗急性髓系白血病, objectType=article, longId=177285, objectId=c6391e7285a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6391e7285a6, replyNumber=0, likeNumber=66, createdTime=2020-05-19, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6391e7285a6, moduleTitle=Lancet Haematology：Nivolumab联合一线化疗治疗急性髓系白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6391e7285a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008409, encodeId=12132008409f9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Haematologica：达沙替尼治疗白血病胸腔积液风险增加？, objectType=article, longId=161419, objectId=75c816141913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75c816141913, replyNumber=0, likeNumber=114, createdTime=2019-09-07, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75c816141913, moduleTitle=Haematologica：达沙替尼治疗白血病胸腔积液风险增加？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75c816141913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008440, encodeId=c4f22008440ae, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：抗抑郁药与硬膜下血肿风险, objectType=article, longId=181251, objectId=245818125102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245818125102, replyNumber=0, likeNumber=76, createdTime=2020-01-07, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245818125102, moduleTitle=J Thromb Haemost：抗抑郁药与硬膜下血肿风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245818125102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008431, encodeId=b0672008431c0, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：孕妇产后静脉血栓栓塞危险因素患病率分析, objectType=article, longId=175690, objectId=a2d81e56903c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d81e56903c, replyNumber=0, likeNumber=65, createdTime=2019-12-14, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d81e56903c, moduleTitle=J Thromb Haemost：孕妇产后静脉血栓栓塞危险因素患病率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d81e56903c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HAE

2020-05-29

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：血浆中甘露糖结合凝集素水平与静脉血栓栓塞风险

2020-05-19

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haemat：Guadecitabine用于中高危骨髓增生异常综合征患者的疗效和安全性

2019-12-13

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：静脉血栓栓塞后的身体活动与复发风险以及死亡率的关系

2019-07-13

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：阿哌沙班和达肝素在活动性恶性肿瘤相关的静脉血栓栓塞中的疗效

2020-09-20

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haemat： Polatuzumab vedotin或Pinatuzumab vedotin联合利妥昔单抗用于复发性/难治性非霍奇金淋巴瘤的疗效

2020-03-09

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：抗胸腺蛋白抗体联合标准GVHD预防疗法可明显改善非亲缘供体移植血液恶性肿瘤患者的预后

2020-04-08

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：新诊断MM诱导治疗反应深度不佳者强化治疗可进一步改善结果

2020-02-01

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematology：来那度胺联合Obinutuzumab单抗治疗复发或难治性滤泡性淋巴瘤

2019-09-06

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：直接口服抗凝药会增加脑肿瘤患者颅内出血风险吗？

2019-04-02

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：新确诊急性髓性白血病老年患者：地西他滨5天vs 10天方案

2019-10-31

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：全血细胞计数、d-二聚体和可溶性P-选择素与癌症患者动脉血栓栓塞风险的关联

2020-04-11

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haemat：A型血友病患者采用emicizumab预防出血的效果和安全性

2020-01-07

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haemat：沙班类抗凝药用于病态肥胖患者的效果和安全性是否可媲美华法林？

2020-02-16

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：慢性免疫性血小板减少症患者心血管和出血结局

2019-06-20

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：Emicizumab用于A型血友病出血预防

2019-07-18

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：血液系统癌症患者血栓栓塞和出血的风险

2020-02-06

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematology：Nivolumab联合一线化疗治疗急性髓系白血病

2020-05-19

changfy (审核中...)

前往app查看评论内容

#HAE#

Haematologica：达沙替尼治疗白血病胸腔积液风险增加？

2019-09-07

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：抗抑郁药与硬膜下血肿风险

2020-01-07

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：孕妇产后静脉血栓栓塞危险因素患病率分析

2019-12-14

科室
- - 订阅+
  - 更多科室
工具
服务